CytoSorbents Corp.
(NASDAQ : CTSO)

( )
CTSO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.95%582.821.0%$844.15m
DHRDanaher Corp. 0.26%301.200.7%$674.24m
ABTAbbott Laboratories -0.09%117.460.8%$620.40m
MDTMedtronic Plc 2.32%127.700.6%$526.13m
ALGNAlign Technology, Inc. -1.36%589.616.3%$337.47m
BDXBecton, Dickinson & Co. -0.61%241.201.0%$335.40m
ISRGIntuitive Surgical, Inc. 0.17%331.500.8%$317.01m
SYKStryker Corp. 0.96%266.381.3%$284.16m
DXCMDexCom, Inc. -1.81%544.477.8%$282.68m
IDXXIDEXX Laboratories, Inc. 0.86%635.153.8%$276.25m
EWEdwards Lifesciences Corp. 0.59%112.230.4%$260.36m
BSXBoston Scientific Corp. 0.44%43.441.0%$256.50m
AAgilent Technologies, Inc. 0.54%153.421.6%$222.45m
BAXBaxter International, Inc. -0.26%79.681.8%$200.18m
ZBHZimmer Biomet Holdings, Inc. 0.81%146.811.7%$174.98m

Company Profile

CytoSorbents Corp. engages in the critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio include CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ.